3 Unstoppable Value Stocks to Buy in September (1 Yields 7.3%)

The article highlights three consumer-oriented value stocks: Universal Corp., yielding roughly 7.3% after its 56th consecutive annual dividend increase; Hamilton Beach, whose Q2 revenue rose 11.6% to $142.6 million but was materially aided by a $36.5 million tariff refund; and John B. Sanfilippo, which is investing about $90 million in bar-production lines targeting roughly $300 million of incremental sales over three to four years. Universal faces weak consumer-packaged-goods demand and margin pressure, while Hamilton Beach must demonstrate normalized sales and margins after temporary tariff benefits. Sanfilippo's capacity buildout, CEO transition effective Oct. 1, strong balance sheet, and AI cost-reduction initiatives are presented as longer-term catalysts.

Analysis

The apparent UVV yield support should be treated as a credit-like equity thesis, not a growth rerating. With tobacco structurally ex-growth and the ingredients buildout carrying fixed-cost absorption risk, even modest volume misses can pressure dividend coverage and force the market to demand a higher yield; a 100bp yield expansion would be materially adverse to the share price. The relevant 1-3 month catalyst is evidence of ingredients gross-margin recovery, while the 6-18 month question is whether returns on expansion exceed the cost of capital rather than simply add revenue.

HBB's reported earnings quality is unusually vulnerable to normalization: a nonrecurring cash benefit can mask underlying sell-through, promotional spending needs, and the earnings hole left by discontinued licensing relationships. Its asset-light structure reduces manufacturing capital needs but concentrates risk in retailer inventory cycles and contract renewal economics; CLX is not a meaningful read-through because licensing revenue is unlikely to be material to its consolidated results. There is no clean directional trade until normalized operating income, excluding tariff items, and post-contract revenue retention are disclosed.

JBSS is the highest-potential but most execution-sensitive setup. Incremental capacity creates operating leverage only after retailer listings and utilization clear breakeven; before that, depreciation, startup waste, and working-capital investment can dilute returns despite a strong balance sheet. The market may underappreciate that private-label snack customers possess substantial bargaining power, so capacity fill could come at lower-than-expected margins; the key falsifier is whether gross margin and inventory turns improve as volume ramps, rather than merely whether management reiterates long-range sales capacity.

Key Decisions for Investors

• JBSS: place on a 1-3 month accumulation watch, not a full-size entry. Initiate only after the first production-line update shows measurable customer commitments and stable gross margin; target a 6-18 month capacity-ramp thesis. Exit or avoid if inventory growth materially exceeds sales growth for two consecutive quarters or if capex/working-capital needs push free cash flow negative beyond the ramp period.
• UVV: maintain only a yield-sized position and require a dividend-coverage monitor. Add only if ingredients segment margins recover sequentially without a tobacco-volume deterioration; reduce if the implied equity yield moves above roughly 8.3%, signaling that the market is repricing payout durability rather than discounting temporary weakness.
• HBB: avoid extrapolating the tariff-related earnings benefit into valuation. Set an alert for the next results release: consider a long only if organic revenue and normalized operating margin improve despite the absence of one-time items; otherwise, a short or underweight becomes attractive if consensus earnings still embeds the elevated quarter as a baseline.
• Do not use CLX, NFLX, or NVDA as sympathy trades from this item. The promotional references and brand association do not establish a sufficiently material earnings transmission mechanism.